Suppr超能文献

[法国苯二氮䓬类药物的使用与滥用情况]

[Benzodiazepine use and misuse in France].

作者信息

Bénard-Laribière Anne, Pariente Antoine

机构信息

University of Bordeaux, Inserm, Bordeaux Population Health Research Center, team Pharmacoepidemiology, UMR 1219, 33076 Bordeaux, France; DRUGS-SAFE National Platform of Pharmacoepidemiology, 33076 Bordeaux, France.

University of Bordeaux, Inserm, Bordeaux Population Health Research Center, team Pharmacoepidemiology, UMR 1219, 33076 Bordeaux, France; DRUGS-SAFE National Platform of Pharmacoepidemiology, 33076 Bordeaux, France; University Hospital of Bordeaux, Clinical Pharmacology, 33076 Bordeaux, France.

出版信息

Presse Med. 2018 Oct;47(10):878-881. doi: 10.1016/j.lpm.2018.10.005. Epub 2018 Oct 25.

Abstract

Benzodiazepine use remains high in France in 2015, especially among the elders. However, encouraging trend is observed regarding hypnotic benzodiazepines initiation: between 2008 and 2015, incident use of hypnotics, including that of Z-drugs, decreased while incident use of anxiolytics remained stable. Most of new benzodiazepine users (86 %) had treatment duration that complies with guidelines. Owing to the high number of user initiating a treatment each year and associated risks, the remaining 14 % of long-term users is of concern. Roughly half of benzodiazepine users presented with comorbidities and concurrent medications increasing the risk of adverse drug reactions, especially central nervous system depressant effects.

摘要

2015年,法国苯二氮䓬类药物的使用量仍然很高,尤其是在老年人中。然而,在催眠性苯二氮䓬类药物的起始使用方面观察到了令人鼓舞的趋势:在2008年至2015年期间,包括Z类药物在内的催眠药的新使用量有所下降,而抗焦虑药的新使用量保持稳定。大多数新的苯二氮䓬类药物使用者(86%)的治疗持续时间符合指南。由于每年开始治疗的使用者数量众多以及相关风险,其余14%的长期使用者令人担忧。大约一半的苯二氮䓬类药物使用者患有合并症并同时使用多种药物,这增加了药物不良反应的风险,尤其是中枢神经系统抑制作用。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验